MESFIN FREW: Open Payments
NPI 1962760199 · JESSUP, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66 in 3 payments from 3 companies in 2025. Trend: 2023 $56 · 2024 $0 · 2025 $66
Food & beverage: $66
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: ZERBAXA, EMBLAVEO, Veklury.
Industry payments across MD — which companies pay providers there.
